Docetaxel in Treating Women With Ovarian Epithelial or Primary Peritoneal Cancer

NCT00004081 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Ovarian Cancer
Peritoneal Cavity Cancer

Interventions

DRUG: docetaxel

Sponsor

Beth Israel Deaconess Medical Center